Senthil H, Streilein S, Whiteside T, Minuk L, Landego I, Kotb R, Menard C, Kansara R, Moltzan CJ, Johnston JB, Skrabek P, Yang L, Geirnaert M, Banerji V. Real-world safety and tolerability of rapid infusion obinutuzumab in chronic lymphocytic leukemia, small lymphocytic lymphoma and non-Hodgkin lymphoma: a provincial review. Haematologica; https://doi.org/10.3324/haematol.2025.288780 [Early view].